Stay updated on Abilify MyCite® in Schizophrenia 6-Month Clinical Trial
Sign up to get notified when there's something new on the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page.

Latest updates to the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRecruitment is closed for this study, and new guidance sections were added to help users read the study record and join the study, while the Intervention/Treatment label was reformatted and the page revision updated to v3.6.0.SummaryDifference0.3%

- Check15 days agoChange DetectedThe page now shows Revision: v3.5.5 (replacing v3.5.4), and the related topics entries for Schizophrenia and MedlinePlus Genetics have been removed.SummaryDifference0.1%

- Check22 days agoChange DetectedThe related topics section now includes Schizophrenia and MedlinePlus Genetics, providing direct access to condition-specific information.SummaryDifference0.1%

- Check37 days agoChange DetectedThe revision label was updated from v3.5.3 to v3.5.4, indicating a small update to the page’s metadata. This change does not modify study details or content.SummaryDifference0.0%

- Check44 days agoChange DetectedSchizophrenia is removed from the study context and the related topics section no longer lists MedlinePlus Genetics. This changes how the study's focus is presented and what background resources are linked on the page.SummaryDifference0.1%

- Check51 days agoChange DetectedRevision: v3.5.3 replaces the previous v3.5.2 label on the page, signaling a new version of the page/document. This reflects version control activity rather than a substantive change to the study details.SummaryDifference0.0%

Stay in the know with updates to Abilify MyCite® in Schizophrenia 6-Month Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Abilify MyCite® in Schizophrenia 6-Month Clinical Trial page.